바이오로직스 자료
Accelerated High Performance Cell Line Development at Samsung Biologics
The decision by any institution on the selected host cell line impacts the quality, cost of goods, and speed of the development process.
Through this poster, the Samsung Biologics CDO R&D Team describes our accelerated platform, cell line development, and the compelling study outcome of its new proprietary cell line.
With our fast development timeline by 3 months and significantly high titer results from our proprietary cell line, Samsung Biologics provides our partners an option to proceed to IND Faster & Better.
The decision by any institution on the selected host cell line impacts the quality, cost of goods, and speed of the development process.
Through this poster, the Samsung Biologics CDO R&D Team describes our accelerated platform, cell line development, and the compelling study outcome of its new proprietary cell line.
With our fast development timeline by 3 months and significantly high titer results from our proprietary cell line, Samsung Biologics provides our partners an option to proceed to IND Faster & Better.
- Attached